Hidden Inflammation Drives High Colon Cancer Risk, Garvan Research Reveals
According to recent research published in Nature Communications by the Garvan Institute of Medical Research, primary sclerosing cholangitis (PSC) and ulcerative colitis are fundamentally different bowel diseases despite currently receiving identical treatments. The findings reveal why PSC patients face a colorectal cancer risk three times higher than those with ulcerative colitis alone, offering new pathways … Read more